Navigation Links
WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
Date:11/27/2008

SHANGHAI, China, Nov. 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced Edward Hu, the Company's Chief Operating Officer, will present at the 20th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2008, at 12:00 pm Eastern Standard Time.

(Photo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The Company will broadcast its presentation. Interested parties may access the broadcast through the Investor Relations section of the Company's web site: http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

    Form more information, please contact:

     Debra Yu, MD
     Vice President Strategy
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +1-215-218-5559
     Email: ir@wuxiapptec.com

     Dr. Hai Mi
     Executive Director of Investor Relations and Business Planning
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +86-21-5046-3726
     Email: ir@wuxiapptec.com

     Juliane Snowden
     Vice President of Investor Relations
     Burns McClellan
     Tel:   +1-212-213-0006
     Email: Jsnowden@burnsmc.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WuXi PharmaTech Expands Collaboration for Fully Integrated Services
2. WuXi PharmaTech Announces Second Quarter 2008 Results
3. WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
4. Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
5. WuXi PharmaTech 2007 Annual Report Available Online
6. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
7. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
8. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
9. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
10. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
11. WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... ... today the continuation of the ‘Pay It Forward’ program into 2016. BioPlus partners ... at our specialty pharmacy. , “Since our Pay It Forward program began, ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Boston Store, Carson’s, Elder-Beerman, Herberger’s and Younkers department stores, announced it has raised ... of Wisconsin Cancer Center, Holden Comprehensive Cancer Center at the University of Iowa, ...
(Date:2/9/2016)... ... February 09, 2016 , ... IsoComforter, Inc., ... introduction of the newly designed, innovative shoulder wrap. The newly designed shoulder ... for the injured arm and shoulder to promote faster healing. It is highly ...
(Date:2/9/2016)... ... , ... i2i Systems, an early innovator and developer of population health management ... KLAS report, Population Health Management 2015: How Far Can Your Vendor Take You? ... (PHM). The latest KLAS Report, leveraging over 200 user interviews, shines a light ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... its newly redesigned website, federallabs.org . The site houses a wealth of ... available federal technologies through the process called technology transfer (T2). As a network ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced further details of three new ... aspects of Lewy body dementia, a disease affecting ... out of the three studies were recently initiated ... this quarter. In addition, the Company reported financial ...
(Date:2/9/2016)... SAN FRANCISCO , February 9, 2016 ... a biotechnology company focused on developing products for Regenerative ... will be a featured presenting company at Source Capital ... place on February 10-11, 2016 in New ... given on Wednesday, February 10, 2016 at 12:30 pm ...
(Date:2/9/2016)... -- The global prefilled syringes market accounted for $3,905.1 ... grow with a CAGR of 12.9% during 2015-2020. Among ... the global prefilled syringes market, with 90.1% share in ... The global market of prefilled syringes is up surging ... increasing demand for vaccines, increasing prevalence of chronic and ...
Breaking Medicine Technology: